Cargando…
ERGO: A pilot study of ketogenic diet in recurrent glioblastoma
Limiting dietary carbohydrates inhibits glioma growth in preclinical models. Therefore, the ERGO trial (NCT00575146) examined feasibility of a ketogenic diet in 20 patients with recurrent glioblastoma. Patients were put on a low-carbohydrate, ketogenic diet containing plant oils. Feasibility was the...
Autores principales: | RIEGER, JOHANNES, BÄHR, OLIVER, MAURER, GABRIELE D., HATTINGEN, ELKE, FRANZ, KEA, BRUCKER, DANIEL, WALENTA, STEFAN, KÄMMERER, ULRIKE, COY, JOHANNES F., WELLER, MICHAEL, STEINBACH, JOACHIM P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4063533/ https://www.ncbi.nlm.nih.gov/pubmed/24728273 http://dx.doi.org/10.3892/ijo.2014.2382 |
Ejemplares similares
-
Maintenance of Energy Homeostasis during Calorically Restricted Ketogenic Diet and Fasting-MR-Spectroscopic Insights from the ERGO2 Trial
por: Wenger, Katharina J., et al.
Publicado: (2020) -
Differential utilization of ketone bodies by neurons and glioma cell lines: a rationale for ketogenic diet as experimental glioma therapy
por: Maurer, Gabriele D, et al.
Publicado: (2011) -
Short-term fasting in glioma patients: analysis of diet diaries and metabolic parameters of the ERGO2 trial
por: Voss, Martin, et al.
Publicado: (2021) -
Phospholipid Metabolites in Recurrent Glioblastoma: In Vivo Markers Detect Different Tumor Phenotypes before and under Antiangiogenic Therapy
por: Hattingen, Elke, et al.
Publicado: (2013) -
Rescue of 2-Deoxyglucose Side Effects by Ketogenic Diet
por: Voss, Martin, et al.
Publicado: (2018)